LEADER 03721nam 2200625Ia 450 001 9910815939903321 005 20200520144314.0 010 $a1-282-45614-8 010 $a9786612456145 010 $a92-4-068424-7 035 $a(CKB)2550000000005665 035 $a(EBL)476161 035 $a(OCoLC)609852935 035 $a(SSID)ssj0000367559 035 $a(PQKBManifestationID)11265667 035 $a(PQKBTitleCode)TC0000367559 035 $a(PQKBWorkID)10311380 035 $a(PQKB)10081559 035 $a(MiAaPQ)EBC476161 035 $a(Au-PeEL)EBL476161 035 $a(CaPaEBR)ebr10363981 035 $a(CaONFJC)MIL245614 035 $a(EXLCZ)992550000000005665 100 $a20090523d2009 uf 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aWHO model formulary 2008 /$f[edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill] 205 $a1st ed. 210 $aGeneva $cWorld Health Organization$d2009 215 $a1 online resource (645 pages) 300 $a"Based on the 15th Model list of essential medicines 2007." 300 $aIncludes index. 311 0 $a92-4-154765-0 327 $aWHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes 327 $a12. Cardiovascular medicines; 13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals; Appendix 1: Interactions; Appendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index 330 $aSince its first publication in 2002, the WHO Model Formulary has become an indispensable source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. The Model Formulary is the authoritative guide on how to make effective use of the medicines on the WHO Model List of Essential Medicines, so improving patient safety, and limiting unnecessary medical spending. For each medicine the Model Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine fo 606 $aMedicine$vFormulae, receipts, prescriptions 606 $aDrugs$xPrescribing 615 0$aMedicine 615 0$aDrugs$xPrescribing. 676 $a615.13 701 $aStuart$b Mark C$01676685 701 $aKouimtzi$b Maria$01676686 701 $aHill$b Suzanne$0877980 712 02$aWorld Health Organization. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910815939903321 996 $aWHO model formulary 2008$94043026 997 $aUNINA